Courier Capital LLC Purchases 543 Shares of Stryker Co. (NYSE:SYK)

Courier Capital LLC lifted its position in Stryker Co. (NYSE:SYK) by 19.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 3,357 shares of the medical technology company’s stock after purchasing an additional 543 shares during the quarter. Courier Capital LLC’s holdings in Stryker were worth $1,201,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Burkett Financial Services LLC bought a new stake in Stryker during the 4th quarter worth about $25,000. Farmers & Merchants Trust Co of Chambersburg PA grew its holdings in Stryker by 203.3% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. Rogco LP bought a new stake in Stryker during the 4th quarter worth about $30,000. DSM Capital Partners LLC bought a new stake in Stryker during the 4th quarter worth about $34,000. Finally, HBC Financial Services PLLC bought a new stake in Stryker during the 4th quarter worth about $37,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on SYK shares. Roth Mkm increased their price objective on shares of Stryker from $348.00 to $405.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. StockNews.com upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday. Citigroup upped their target price on shares of Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Royal Bank of Canada upped their target price on shares of Stryker from $360.00 to $386.00 and gave the company an “outperform” rating in a research report on Monday, April 15th. Finally, Evercore ISI upped their target price on shares of Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, Stryker presently has an average rating of “Moderate Buy” and a consensus target price of $370.58.

Stryker Stock Performance

Shares of SYK stock opened at $340.43 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The company has a market capitalization of $129.69 billion, a P/E ratio of 38.86, a price-to-earnings-growth ratio of 2.68 and a beta of 0.92. The company’s 50 day moving average price is $337.38 and its two-hundred day moving average price is $333.39. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $361.41.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.36 by $0.14. The firm had revenue of $5.24 billion for the quarter, compared to the consensus estimate of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The business’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period last year, the company posted $2.14 EPS. On average, analysts expect that Stryker Co. will post 11.95 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be paid a dividend of $0.80 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 annualized dividend and a dividend yield of 0.94%. Stryker’s dividend payout ratio is currently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.